Abstract
A quantitative cylinder plate bioassay for sulbactam has been developed which can detect concentrations as low as 0.01 microgram/g in bovine muscle, fat, kidney, and liver tissues. This procedure may also be applicable to human tissues and fluids. In addition to the improved sensitivity, this method differs from all previously described systems because it is based on inhibition by sulbactam of a cell-free beta-lactamase incorporated in the assay agar. The assay is unaffected by the presence of ampicillin even at concentrations 10 times that of the sulbactam concentration. This report describes the analytical technique as well as the accuracy and precision of the method. The assay can be applied to tissue depletion studies.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown R. M., Wise R., Andrews J. M., Hancox J. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother. 1982 Apr;21(4):565–567. doi: 10.1128/aac.21.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dardas R. B., Perry J. H., Coles Z. A., Iwanicki C. G. Automated plate diffusion zone measurement and computerized data handling. Bull Parenter Drug Assoc. 1973 Jul-Aug;27(4):185–194. [PubMed] [Google Scholar]
- English A. R., Girard D., Haskell S. L. Pharmacokinetics of sultamicillin in mice, rats, and dogs. Antimicrob Agents Chemother. 1984 May;25(5):599–602. doi: 10.1128/aac.25.5.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- English A. R., Retsema J. A., Girard A. E., Lynch J. E., Barth W. E. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. Antimicrob Agents Chemother. 1978 Sep;14(3):414–419. doi: 10.1128/aac.14.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foulds G., Gans D. J., Girard D., Whall T. J. Assays of sulbactam in the presence of ampicillin. Ther Drug Monit. 1986;8(2):223–227. doi: 10.1097/00007691-198606000-00018. [DOI] [PubMed] [Google Scholar]
- Nelson J. D., Kusmiesz H., Shelton S. Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients. Antimicrob Agents Chemother. 1982 Apr;21(4):681–682. doi: 10.1128/aac.21.4.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Retsema J. A., English A. R., Girard A. E. CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother. 1980 Apr;17(4):615–622. doi: 10.1128/aac.17.4.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright N., Wise R. The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction. J Antimicrob Chemother. 1983 Jun;11(6):583–587. doi: 10.1093/jac/11.6.583. [DOI] [PubMed] [Google Scholar]